Hadassah

Hadassah Cancer Specialists Explore Link Between Colorectal Cancer and BRCA Mutations

Wednesday, Jul 11 2018

Looking further into the link between colorectal cancer and BRCA 1 and 2 genetic mutations, researchers from the Hadassah Medical Center’s Sharett Institute of Oncology, together with colleagues from Chaim Sheba Medical Center, analyzed data from 32 patients with lower gastrointestinal cancers. Nearly 63 percent of the patients were BRCA 1 carriers, and two of the patients also had anal cancer.

Though mucinous tumors are typically rare and are usually situated in the right side of the colon, carriers of the BRCA mutations were more than twice as likely to have mucinous tumors than non-BRCA carriers, and their tumors are mostly on the left side of the colon. According to the researchers, they may also have a better prognosis.

These findings led the researchers to suggest that “Ashkenazi BRCA 1 and 2 mutation carriers with colorectal cancer might have characteristics that are unique to them—that is, for example, a high rate of left-sided cancer, with what is called a mucinous histology, and accompanied by anal cancer.” For that reason, treatment may require different approaches.

The study is highlighted in the January 10, 2018, issue of European Journal of Human Genetics. 

Related Stories

alt_text

Wednesday, Dec 2 2020

Hadassah Opens Follow-Up Clinic for Recovered COVID-19 Patients

In response to the large number of COVID-19 patients suffering from lingering health issues long after they recover from the virus, Hadassah Hospital Ein Kerem has opened a multidisciplinary clinic at its Pulmonary Institute to monitor and assess their physical and psychological symptoms.

READ MORE ›
alt_text

Tuesday, Dec 1 2020

One in 200,000: Identical Triplets Born at Hadassah Hospital Mount Scopus

Last year, Tamar gave birth to a stillborn baby. When she became pregnant again, she initially didn’t rush to have an ultrasound because of the pandemic. But she wanted to make sure there was a heartbeat, and so she went to Hadassah Hospital Mount Scopus for that ultrasound. There were three heartbeats—belonging to three identical babies!

READ MORE ›
alt_text

Tuesday, Dec 1 2020

Hadassah Completes Phase I Trial With Israeli-Made COVID-19 Vaccine

Phase I of the first clinical trial with Brilife, the COVID-19 vaccine developed by the Israel Institute for Biological Research, was completed at Hadassah Hospital Ein Kerem on November 26, when the 40th participant received the final dose.

READ MORE ›
alt_text

Tuesday, Nov 24 2020

[Hadassah On Call Podcast] COVID's Long-Term Health Impact, an Insider's Perspective

It's no longer enough to find a COVID-19 cure. Each day, we're discovering long-term complications for those who have recovered from the virus.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Israel Travel

israeltravel@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

More ›

Show More